500 related articles for article (PubMed ID: 10382094)
21. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
[TBL] [Abstract][Full Text] [Related]
22. Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
Périé S; Montravers F; Kerrou K; Angelard B; Tassart M; Talbot JN; Lacau St Guily J
Ann Otol Rhinol Laryngol; 2002 Sep; 111(9):763-71. PubMed ID: 12296328
[TBL] [Abstract][Full Text] [Related]
23. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
[TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
[TBL] [Abstract][Full Text] [Related]
25. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
27. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.
Balogova S; Périé S; Kerrou K; Grahek D; Montravers F; Angelard B; Susini B; El Chater P; St Guily JL; Talbot JN
Mol Imaging Biol; 2008; 10(6):364-73. PubMed ID: 18668293
[TBL] [Abstract][Full Text] [Related]
28. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
Ke Z; Liu M; Liu Y; He Z; Zhang Y; Zhang W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):243-5. PubMed ID: 16739373
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
31. FDG PET/MR for lymph node staging in head and neck cancer.
Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J
Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
[TBL] [Abstract][Full Text] [Related]
32. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Schmid RA; Hautmann H; Poellinger B; Kellner W; Moisseev A; Brinkbaeumer K; Weiss M; Hahn K; Dresel S
Nucl Med Commun; 2003 Jan; 24(1):37-45. PubMed ID: 12501018
[TBL] [Abstract][Full Text] [Related]
33. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
[TBL] [Abstract][Full Text] [Related]
34. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Dale E; Moan JM; Osnes TA; Bogsrud TV
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
[TBL] [Abstract][Full Text] [Related]
35. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
Stokkel MP; Bakker PF; Heine R; Schlösser NJ; Lammers JW; Van Rijk PP
Nucl Med Commun; 1999 Nov; 20(11):1001-7. PubMed ID: 10572909
[TBL] [Abstract][Full Text] [Related]
36. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
38. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
39. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K
Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594
[TBL] [Abstract][Full Text] [Related]
40. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]